The short answer
KPV is three amino acids from the tail end of α-MSH; in cell and mouse studies it enters cells and blocks NF-κB, the master switch for inflammatory signals. BPC-157 is derived from a protective protein in human gastric juice and, in animal studies, speeds the repair of tendons, ligaments, muscle and gut lining. For the gut they’re paired as two angles: KPV damps the inflammatory signal upstream, BPC-157 supports healing of the gut lining downstream.
Side by side
| Compared | KPV | BPC-157 |
|---|---|---|
| Category | Healing & recovery | Healing & recovery |
| Also known as | Lys-Pro-Val, α-MSH tripeptide | Body Protection Compound 157, BPC157 |
| What it is | One of the smallest bioactive peptides: three amino acids from the tail end of α-MSH. | A peptide derived from a protective protein in your stomach. |
| How it works | C-terminal tripeptide of α-MSH. A potent anti-inflammatory in cell and mouse studies that works mainly inside cells rather than through melanocortin receptors: it enters through the PepT1 transporter and blocks NF-κB signaling. In mice it eased colitis and damped allergic skin reactions; as eye drops it sped corneal wound healing in rabbits; in lab dishes it slowed Staphylococcus aureus and Candida albicans. | Synthetic pentadecapeptide derived from a protein in human gastric juice. In animal studies it promotes angiogenesis, speeds tendon, ligament and muscle healing, modulates dopamine and serotonin systems, and protects the gut lining. |
| Commonly reported | A calmer gut and calmer skin. No human study has tested it yet. | Faster recovery from tendon and ligament injuries, and a calmer gut. It's one of the most widely used peptides in the community; the human studies so far are three small uncontrolled pilots. |
| Studied range | Research range: 100–300 mcg. Studied in research — not a recommendation. | Research range: 200–500 mcg. Studied in research — not a recommendation. |
| How often | Daily | Once or twice daily |
| Half-life | Not measured: no half-life for KPV has been published, in people or animals | ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes) |
| Route | SubQ injection, Oral | SubQ injection, IM injection, Oral (less studied) |
| Typical run | 4–8 weeks typical for gut protocols. Can reassess after each cycle. | Typically 4–12 weeks. Many run until injury resolves then stop. Some run indefinitely at lower doses. Opinions vary widely. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection site irritation, mild nausea | Nausea (rare), injection site irritation, vivid dreams, dizziness |
- Category
- KPVHealing & recovery
- BPC-157Healing & recovery
- Also known as
- KPVLys-Pro-Val, α-MSH tripeptide
- BPC-157Body Protection Compound 157, BPC157
- What it is
- KPVOne of the smallest bioactive peptides: three amino acids from the tail end of α-MSH.
- BPC-157A peptide derived from a protective protein in your stomach.
- How it works
- KPVC-terminal tripeptide of α-MSH. A potent anti-inflammatory in cell and mouse studies that works mainly inside cells rather than through melanocortin receptors: it enters through the PepT1 transporter and blocks NF-κB signaling. In mice it eased colitis and damped allergic skin reactions; as eye drops it sped corneal wound healing in rabbits; in lab dishes it slowed Staphylococcus aureus and Candida albicans.
- BPC-157Synthetic pentadecapeptide derived from a protein in human gastric juice. In animal studies it promotes angiogenesis, speeds tendon, ligament and muscle healing, modulates dopamine and serotonin systems, and protects the gut lining.
- Commonly reported
- KPVA calmer gut and calmer skin. No human study has tested it yet.
- BPC-157Faster recovery from tendon and ligament injuries, and a calmer gut. It's one of the most widely used peptides in the community; the human studies so far are three small uncontrolled pilots.
- Studied range
- KPVResearch range: 100–300 mcg. Studied in research — not a recommendation.
- BPC-157Research range: 200–500 mcg. Studied in research — not a recommendation.
- How often
- KPVDaily
- BPC-157Once or twice daily
- Half-life
- KPVNot measured: no half-life for KPV has been published, in people or animals
- BPC-157~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes)
- Route
- KPVSubQ injection, Oral
- BPC-157SubQ injection, IM injection, Oral (less studied)
- Typical run
- KPV4–8 weeks typical for gut protocols. Can reassess after each cycle.
- BPC-157Typically 4–12 weeks. Many run until injury resolves then stop. Some run indefinitely at lower doses. Opinions vary widely.
- Evidence
- KPVEmerging: primarily preclinical / limited human data
- BPC-157Emerging: primarily preclinical / limited human data
- Common side effects
- KPVInjection site irritation, mild nausea
- BPC-157Nausea (rare), injection site irritation, vivid dreams, dizziness
Typical run: Community practice — opinions vary. Not a clinical recommendation.
Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
KPV
- Day 1–7 Week one: your starting point
- Day 7–21 Users often report a calmer gut
- Day 21–42 Some report calmer skin
- Day 42–56 Weeks 6 to 8: taking stock
BPC-157
- Day 1–7 Week one: early hints, for some
- Day 7–14 Pain often starts to ease
- Day 14–21 Pain often eases by week three
- Day 21–28 Many report a calmer gut
- Day 28–42 The slower part of repair
- Day 42–56 Six weeks in: taking stock
- Day 84+ Past week 12, the data runs thin
Together or one or the other
KPV and BPC-157 are a common stack: KPV lists BPC-157 among its common stacks, and they’re together in the KLOW stack.
- KLOW: GLOW plus KPV — four repair peptides in one vial (KPV, BPC-157, TB-500 and GHK-Cu).
Community · KPV
Why KPV pairs with BPC-157 for gut
Two angles on the gut: KPV damps the inflammatory signal upstream, and BPC-157 supports healing of the gut lining downstream. Together they calm the damage and repair it at the same time. Commonly reported: a calmer gut.
Questions people ask
How long do KPV and BPC-157 last?
The half-life of KPV is not measured: no half-life for KPV has been published, in people or animals. The half-life of BPC-157 is ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes).
How often are KPV and BPC-157 taken?
KPV: daily. Routes: SubQ injection, oral. BPC-157: once or twice daily. Routes: SubQ injection, IM injection, oral (less studied).
How are KPV and BPC-157 dosed in research?
The research range for KPV is 100–300 mcg. The research range for BPC-157 is 200–500 mcg. Studied in research — not a recommendation.
What are the common side effects of KPV and BPC-157?
For KPV, the library lists: injection site irritation, mild nausea. For BPC-157: nausea (rare), injection site irritation, vivid dreams, dizziness.
Are KPV and BPC-157 taken together?
KPV and BPC-157 are a common stack: KPV lists BPC-157 among its common stacks, and they’re together in the KLOW stack. Two angles on the gut: KPV damps the inflammatory signal upstream, and BPC-157 supports healing of the gut lining downstream. Together they calm the damage and repair it at the same time. Commonly reported: a calmer gut.
Each one in full
PepVault for iPhone
Track either one in PepVault
Log every dose of KPV or BPC-157, with reminders on your schedule. 7 days free on the yearly plan for new subscribers.
